American Association for Cancer Research
Browse
00085472can076341-sup-sfig_1_tables_1-5.pdf (665.18 kB)

Supplementary Figure 1, Tables 1-5 from The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-α Antitumor Effects

Download (665.18 kB)
journal contribution
posted on 2023-03-30, 18:02 authored by Lidia Moserle, Stefano Indraccolo, Margherita Ghisi, Chiara Frasson, Elena Fortunato, Silvana Canevari, Silvia Miotti, Valeria Tosello, Rita Zamarchi, Alberto Corradin, Sonia Minuzzo, Elisabetta Rossi, Giuseppe Basso, Alberto Amadori
Supplementary Figure 1, Tables 1-5 from The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-α Antitumor Effects

History

ARTICLE ABSTRACT

The side population (SP), recently identified in several normal tissues and in a variety of tumors based on its ability to extrude some fluorescent dyes, may comprise cells endowed with stem cell features. In this study, we investigated the presence of SP in epithelial ovarian cancer and found it in 9 of 27 primary tumor samples analyzed, as well as in 4 of 6 cultures from xenotransplants. SP cells from one xenograft bearing a large SP fraction were characterized in detail. SP cells had higher proliferation rates, were much less apoptotic compared with non-SP cells, and generated tumors more rapidly than non-SP cells. We also investigated the effects of IFN-α, a cytokine that has widely been used to treat solid tumors, on epithelial ovarian cancer cells and observed that IFN-α exerted marked antiproliferative and proapoptotic effects on primary cultures containing high numbers of SP cells. In vitro, IFN-α treatment invariably caused a dramatic reduction in SP size in tumor cell lines of different origins; moreover, IFN-α treatment of purified SP cells was associated with a distinctive change in their transcriptional profile. Gene therapy with human IFN-α resulted in regression of established tumors bearing a large SP fraction, which was not observed when tumors bearing low SP levels were treated. These findings could have relevant clinical implications because they imply that tumors bearing large SP numbers, albeit rare, could be sensitive to IFN-α treatment. [Cancer Res 2008;68(14):5658–68]

Usage metrics

    Cancer Research

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC